Attune Pharmaceuticals is a private biotechnology company focused on discovering and developing novel oral once-daily small-molecule therapeutics for the treatment of rare diseases.
Total raised: $23M
Investors 2
| Date | Name | Website |
| - | RA Capital... | racap.com |
| - | LifeSci Ve... | lifesciven... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 23.01.2019 | Series B | $23M | - | finsmes.co... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 24.01.2019 | Attune Pha... | NEW YORK, NY, Attune Pharmac... | - | - | vcnewsdail... |
| 24.01.2019 | Attune Pha... | Attune Pharmaceuticals, Inc., ... | USA | - | finsmes.co... |
| 23.01.2019 | Attune Pha... | Attune Pharmaceuticals raised ... | Biotech | - | fiercebiot... |
| 23.01.2019 | Attune Pha... | NEW YORK, Jan. 23, 2019 (GLOBE... | - | - | citybizlis... |
| 23.01.2019 | Attune Pha... | Attune Pharmaceuticals raised ... | Biotech | - | fiercebiot... |
| 23.01.2019 | Term Sheet... | CRYPTO CAPITAL Good morning, ... | - | - | fortune.co... |
| 23.01.2019 | Daily fund... | AnChain.ai raised $2M; Chowbus... | - | Kristin Ka... | vator.tv/n... |